Audax Private Equity Acquires Avantor's Clinical Services Business, Rebrands it as Resonant Clinical Solutions

October 18, 2024

Audax Private Equity has completed the acquisition of Avantor, Inc.'s Clinical Services business and rebranded the business as Resonant Clinical Solutions. The divestiture—reported at roughly $650 million—transfers a global clinical trial services platform (EPL Archives, MESM, Therapak) to Audax, which plans to invest in organic and inorganic growth to expand capabilities for pharmaceutical, biotech, CRO, and diagnostic customers.

Buyers
Audax Private Equity
Targets
Clinical Services business of Avantor, Inc. (rebranded as Resonant Clinical Solutions)
Sellers
Avantor, Inc.
Location
United States
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.